- Home
- XTNT
as 11-21-2024 4:00pm EST
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | BELGRADE |
| Market Cap: | 74.1M | IPO Year: | N/A |
| Target Price: | $3.00 | AVG Volume (30 days): | 105.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.13 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.39 - $1.45 | Next Earning Date: | 11-12-2024 |
| Revenue: | $113,862,000 | Revenue Growth: | 45.11% |
| Revenue Growth (this year): | 31.82% | Revenue Growth (next year): | 13.64% |
Latest Xtant Medical Holdings Inc. News
XTNT Breaking Stock News: Dive into XTNT Ticker-Specific Updates for Smart Investing
ACCESSWIRE
10 days ago
Xtant Medical Reports Third Quarter 2024 Financial Results
ACCESSWIRE
11 days ago
Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference
ACCESSWIRE
15 days ago
Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024
MT Newswires
2 months ago
Xtant Medical Launches Cortera System for Spinal Procedures; Shares Rise
ACCESSWIRE
2 months ago
Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System
ACCESSWIRE
2 months ago
Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus
ACCESSWIRE
3 months ago
Xtant Medical Announces $5.0 Million Private Placement
ACCESSWIRE
3 months ago
Xtant Medical to Host Second Quarter 2024 Financial Results Earnings Conference call on August 9, 2024
Compare XTNT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "XTNT Xtant Medical Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.